These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17974725)

  • 1. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations.
    Kemper AR; Hwu WL; Lloyd-Puryear M; Kishnani PS
    Pediatrics; 2007 Nov; 120(5):e1327-34. PubMed ID: 17974725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.
    Yang CF; Liu HC; Hsu TR; Tsai FC; Chiang SF; Chiang CC; Ho HC; Lai CJ; Yang TF; Chuang SY; Lin CY; Niu DM
    Am J Med Genet A; 2014 Jan; 164A(1):54-61. PubMed ID: 24243590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for Pompe disease: an update, 2011.
    Burton BK
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening.
    Pillai NR; Fabie NAV; Kaye TV; Rosendahl SD; Ahmed A; Hietala AD; Jorgenson AB; Lanpher BC; Whitley CB
    Mol Genet Metab; 2023; 140(1-2):107633. PubMed ID: 37414610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in Taiwan.
    Liao HC; Chiang CC; Niu DM; Wang CH; Kao SM; Tsai FJ; Huang YH; Liu HC; Huang CK; Gao HJ; Yang CF; Chan MJ; Lin WD; Chen YJ
    Clin Chim Acta; 2014 Apr; 431():80-6. PubMed ID: 24513544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening + enzyme replacement therapy = improved lysosomal storage disorder: outcomes in infantile-onset Pompe disease.
    Andersson HC
    J Pediatr; 2015 Apr; 166(4):800-1. PubMed ID: 25641241
    [No Abstract]   [Full Text] [Related]  

  • 8. Newborn Screening for Pompe Disease.
    Bodamer OA; Scott CR; Giugliani R;
    Pediatrics; 2017 Jul; 140(Suppl 1):S4-S13. PubMed ID: 29162673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Genetic Counseling in Pompe Disease After Patients Are Identified Through Newborn Screening.
    Atherton AM; Day-Salvatore D;
    Pediatrics; 2017 Jul; 140(Suppl 1):S46-S50. PubMed ID: 29162676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program.
    Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH
    Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pompe disease in infants: improving the prognosis by newborn screening and early treatment.
    Chien YH; Lee NC; Thurberg BL; Chiang SC; Zhang XK; Keutzer J; Huang AC; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2009 Dec; 124(6):e1116-25. PubMed ID: 19948615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Initial Evaluation of Patients After Positive Newborn Screening: Recommended Algorithms Leading to a Confirmed Diagnosis of Pompe Disease.
    Burton BK; Kronn DF; Hwu WL; Kishnani PS;
    Pediatrics; 2017 Jul; 140(Suppl 1):S14-S23. PubMed ID: 29162674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
    Richardson JS; Kemper AR; Grosse SD; Lam WKK; Rose AM; Ahmad A; Gebremariam A; Prosser LA
    Genet Med; 2021 Apr; 23(4):758-766. PubMed ID: 33281187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expert rule-based approach for identifying infantile-onset Pompe disease patients using retrospective electronic health records.
    Rustamov J; Rustamov Z; Mohamad MS; Zaki N; Al Tenaiji A; Al Harbi M; Al Jasmi F
    Sci Rep; 2024 Sep; 14(1):21523. PubMed ID: 39277702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.
    Chien YH; Lee NC; Chen CA; Tsai FJ; Tsai WH; Shieh JY; Huang HJ; Hsu WC; Tsai TH; Hwu WL
    J Pediatr; 2015 Apr; 166(4):985-91.e1-2. PubMed ID: 25466677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public support for neonatal screening for Pompe disease, a broad-phenotype condition.
    Weinreich SS; Rigter T; van El CG; Dondorp WJ; Kostense PJ; van der Ploeg AT; Reuser AJ; Cornel MC; Hagemans ML
    Orphanet J Rare Dis; 2012 Mar; 7():15. PubMed ID: 22413814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should we consider newborn screening for Pompe disease?].
    Lacombe D; Verloes A
    Arch Pediatr; 2014 Jun; 21(6):561-3. PubMed ID: 24768068
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for late-onset Pompe disease in Finland.
    Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B
    Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program.
    Labrousse P; Chien YH; Pomponio RJ; Keutzer J; Lee NC; Akmaev VR; Scholl T; Hwu WL
    Mol Genet Metab; 2010 Apr; 99(4):379-83. PubMed ID: 20080426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to the Newborn Screening, Diagnosis, and Treatment for Pompe Disease Guidance Supplement.
    Kishnani PS; Hwu WL;
    Pediatrics; 2017 Jul; 140(Suppl 1):S1-S3. PubMed ID: 29162672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.